
Zhongxin Yu MD
Anatomic Pathology, Clinical Pathology, Pediatric Pathology
Assistant Professor, Pathology (Clinical), University of Oklahoma College
Join to View Full Profile
940 Stanton L Young BlvdBMSB 451Oklahoma City, OK 73104
Phone+1 405-271-2451
Fax+1 405-271-3064
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Zhongxin Yu, MD is a board certified pathologist in Oklahoma City, Oklahoma. She is currently licensed to practice medicine in Oklahoma and Ohio. She is an Assistant Professor at University of Oklahoma College.
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Pathology, 2007 - 2008
- University of Oklahoma Health Sciences CenterResidency, Pathology-Anatomic and Clinical, 2003 - 2007
- Qingdao University Medical CollegeClass of 1983
Certifications & Licensure
- OK State Medical License 2005 - 2025
- OH State Medical License 2007 - 2008
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Pediatric
Publications & Presentations
PubMed
- Serum adropin is unaltered in adolescents with histology-confirmed steatotic liver disease.Jordan A Bays, Alyssa M Bartlett, Alison M Boone, Youngsil Kim, Zhongxin Yu
Journal of Pediatric Gastroenterology and Nutrition. 2025-01-01 - Automatic renal carcinoma biopsy guidance using forward-viewing endoscopic optical coherence tomography and deep learning.Chen Wang, Haoyang Cui, Qinghao Zhang, Paul Calle, Yuyang Yan
Communications Engineering. 2024-08-02 - 1 citationsChylomicron retention disease: a rare aetiology of failure to thrive.Yojana Sunkoj, Zhongxin Yu, Adnan Altaf, Saurabh Talathi
BMJ Case Reports. 2024-05-14
Press Mentions
- Researchers Use Optical Imaging Technology to Evaluate Transplant Viability of Donor KidneysNovember 2nd, 2022